Welcome to the Most Comprehensive Forum for Microbiome Drug Developers
The microbiome holds the potential to be key in the treatment of multiple disease indications, and with the recent late stage clinical successes, microbiome therapeutics are closer than ever to becoming a commercial reality. However, this excitement and potential is met with an equal amount of challenges unique to this space.
The field has only just begun to scratch the surface of understanding the microbiome’s full impact on human disease, and by bringing together experts in the field who are approaching this challenges from every angle, the 6th Microbiome Movement – Drug Development Summit will enable the community to synergistically accelerate unleashing the complete therapeutic power of the microbiome.
Whether your efforts are focused on the discovery of therapeutic targets, you’re looking to progress your candidate through the clinic, or you are just interested in learning more about the state of the field, join the Microbiome Movement as we explore the global advances in translational microbiome research, and meet like-minded peers who are continuing to understand the causal and therapeutic potential of the microbiome.
Access the official 2021 agenda to see the topics that will be addressed
4 Areas that Define the Drug Development Summit
Understanding Microbiome Function & Pre-Clinical Development
Clinical Translation & Manufacturing of Microbiome Therapeutics
Microbiome Biomarkers, Patient Stratification & Diagnostics
Pre-Conference Immune-Disease Focus Day
Learn the approaches and platforms being harnessed to identify new therapeutic targets to see how you can incorporate the latest scientific findings into your own product pipeline
Hear from subject experts on the major challenges of translating microbiome products through the clinic in order to learn how you can move your products closer to approval and commercialization
Mine the human microbiome to discover new biomarkers and uncover how biomarkers are being used in clinical development in order to better stratify patients and improve clinical outcomes
Explore the latest science understanding the causal role of the microbiome in the development of immune-based diseases, to better inform development of candidates focused on IBD and immune-oncology
Hear What the Microbiome Community Says
"By bringing together experts in the field who are approaching this challenge from
every angle, we can synergistically accelerate unleashing the complete therapeutic
power of the microbiome”
Emily Drabant Conley, Federation Bio
“I am excited about the opportunity to discuss openly with key stakeholders in our field the next frontiers we collectively see and the most critical challenges we face in translating our research to the clinic”
Stephanie Culler, Persephone Biosciences
